Cargando…

Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale

INFECTIOUS AGENT: The severe acute respiratory syndrome (SARS) is a febrile pneumonia initially observed in China at the end of 2002. The infectious agent has rapidly been identified as a new coronavirus, baptised SARS-associated coronavirus (CoV-SARS). Transmission is inter-human, via respiratory p...

Descripción completa

Detalles Bibliográficos
Autores principales: Guihot, Amélie, Bricaire, François, Li, Taisheng, Bossi, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135803/
https://www.ncbi.nlm.nih.gov/pubmed/15041887
http://dx.doi.org/10.1016/S0755-4982(04)98581-8
_version_ 1783518138422263808
author Guihot, Amélie
Bricaire, François
Li, Taisheng
Bossi, Philippe
author_facet Guihot, Amélie
Bricaire, François
Li, Taisheng
Bossi, Philippe
author_sort Guihot, Amélie
collection PubMed
description INFECTIOUS AGENT: The severe acute respiratory syndrome (SARS) is a febrile pneumonia initially observed in China at the end of 2002. The infectious agent has rapidly been identified as a new coronavirus, baptised SARS-associated coronavirus (CoV-SARS). Transmission is inter-human, via respiratory particles mainly. CLINICAL PRESENTATION AND TREATMENT: The clinical presentation is highly variable, from a mild fever to an acute respiratory distress syndrome. There is no specific treatment. Ribavirin associated with steroids have been used with success in numerous cases. EPIDEMIOLOGY: During the first half of 2003, the spreading of the virus has been very fast, with a pandemic mode of evolution. More than 8 000 people were infected and 774 died. The reservoir of the virus, which may be animal, is still unknown. The epidemic seems to be controlled, but sporadic or epidemic re-emergences may occur and have been observed in China duting January 2004.
format Online
Article
Text
id pubmed-7135803
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-71358032020-04-08 Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale Guihot, Amélie Bricaire, François Li, Taisheng Bossi, Philippe Presse Med Article INFECTIOUS AGENT: The severe acute respiratory syndrome (SARS) is a febrile pneumonia initially observed in China at the end of 2002. The infectious agent has rapidly been identified as a new coronavirus, baptised SARS-associated coronavirus (CoV-SARS). Transmission is inter-human, via respiratory particles mainly. CLINICAL PRESENTATION AND TREATMENT: The clinical presentation is highly variable, from a mild fever to an acute respiratory distress syndrome. There is no specific treatment. Ribavirin associated with steroids have been used with success in numerous cases. EPIDEMIOLOGY: During the first half of 2003, the spreading of the virus has been very fast, with a pandemic mode of evolution. More than 8 000 people were infected and 774 died. The reservoir of the virus, which may be animal, is still unknown. The epidemic seems to be controlled, but sporadic or epidemic re-emergences may occur and have been observed in China duting January 2004. Elsevier Masson SAS. 2004-03 2008-01-03 /pmc/articles/PMC7135803/ /pubmed/15041887 http://dx.doi.org/10.1016/S0755-4982(04)98581-8 Text en Copyright © 2004 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Guihot, Amélie
Bricaire, François
Li, Taisheng
Bossi, Philippe
Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale
title Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale
title_full Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale
title_fullStr Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale
title_full_unstemmed Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale
title_short Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale
title_sort syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135803/
https://www.ncbi.nlm.nih.gov/pubmed/15041887
http://dx.doi.org/10.1016/S0755-4982(04)98581-8
work_keys_str_mv AT guihotamelie syndromerespiratoireaigusevereuneepidemiesingulieredepneumonievirale
AT bricairefrancois syndromerespiratoireaigusevereuneepidemiesingulieredepneumonievirale
AT litaisheng syndromerespiratoireaigusevereuneepidemiesingulieredepneumonievirale
AT bossiphilippe syndromerespiratoireaigusevereuneepidemiesingulieredepneumonievirale